October 14, 2014
Corresponding Author: Vicky V. Mody vmody@southuniversity.edu
Department of Pharmaceutical Sciences, College of Pharmacy, South University School of Pharmacy, 709 Mall Blvd, Savannah, GA 31406, USA
<more about author>
Applied Nanoscience, Volume 4, Issue 4, pp 385-392,
Abstract
Tumor hypoxia, or low oxygen concentration, is a result of disordered vasculature that lead to distinctive hypoxic microenvironments not found in normal tissues. Many traditional anti-cancer agents are not able to penetrate into these hypoxic zones, whereas, conventional cancer therapies that work by blocking cell division are not effective to treat tumors within hypoxic zones. Under these circumstances the use of magnetic nanoparticles as a drug delivering agent system under the influence of external magnetic field has received much attention, based on their simplicity, ease of preparation, and ability to tailor their properties for specific biological applications. Hence in this review article we have reviewed current magnetic drug delivery systems, along with their application and clinical status in the field of magnetic drug delivery.
